LifeTech Scientific Balance Sheet Health
Financial Health criteria checks 6/6
LifeTech Scientific has a total shareholder equity of CN¥3.4B and total debt of CN¥99.0M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are CN¥4.8B and CN¥1.4B respectively. LifeTech Scientific's EBIT is CN¥262.5M making its interest coverage ratio -16. It has cash and short-term investments of CN¥1.0B.
Key information
2.9%
Debt to equity ratio
CN¥99.00m
Debt
| Interest coverage ratio | -16x |
| Cash | CN¥1.04b |
| Equity | CN¥3.39b |
| Total liabilities | CN¥1.43b |
| Total assets | CN¥4.82b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1302's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥826.5M).
Long Term Liabilities: 1302's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥602.8M).
Debt to Equity History and Analysis
Debt Level: 1302 has more cash than its total debt.
Reducing Debt: 1302's debt to equity ratio has reduced from 22.7% to 2.9% over the past 5 years.
Debt Coverage: 1302's debt is well covered by operating cash flow (300.6%).
Interest Coverage: 1302 earns more interest than it pays, so coverage of interest payments is not a concern.